Charles River Laboratories International (CRL) Accumulated Depreciation & Amortization: 2009-2025
Historic Accumulated Depreciation & Amortization for Charles River Laboratories International (CRL) over the last 7 years, with Sep 2025 value amounting to $85.2 million.
- Charles River Laboratories International's Accumulated Depreciation & Amortization fell 3.44% to $85.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $427.1 million, marking a year-over-year decrease of 73.22%. This contributed to the annual value of $361.7 million for FY2024, which is 15.16% up from last year.
- Per Charles River Laboratories International's latest filing, its Accumulated Depreciation & Amortization stood at $85.2 million for Q3 2025, which was down 28.74% from $119.5 million recorded in Q2 2025.
- Charles River Laboratories International's 5-year Accumulated Depreciation & Amortization high stood at $1.3 billion for Q4 2023, and its period low was $85.2 million during Q3 2025.
- Over the past 3 years, Charles River Laboratories International's median Accumulated Depreciation & Amortization value was $95.2 million (recorded in 2024), while the average stood at $252.8 million.
- As far as peak fluctuations go, Charles River Laboratories International's Accumulated Depreciation & Amortization crashed by 92.35% in 2024, and later soared by 41.01% in 2025.
- Over the past 5 years, Charles River Laboratories International's Accumulated Depreciation & Amortization (Quarterly) stood at $1.1 billion in 2021, then rose by 5.27% to $1.2 billion in 2022, then rose by 15.00% to $1.3 billion in 2023, then crashed by 92.35% to $102.1 million in 2024, then dropped by 3.44% to $85.2 million in 2025.
- Its Accumulated Depreciation & Amortization was $85.2 million in Q3 2025, compared to $119.5 million in Q2 2025 and $120.4 million in Q1 2025.